Financial News
ACC reports slight rise in sales.
Move adds muscle, joint and back pain relievers to roster.
Investing more than $30 billion in R&D and capital investments in the US over the next four years.
Unit's Q1 gains outpace that of company's overall performance.
Company's consumer healthcare unit has been under review since October.
